TLDR:
- Kidron Capital has launched a new venture capital fund dedicated to women’s health, with a focus on investing in various sectors within the field.
- The fund, led by Maria Gajda Horowitz and Dr. Anula Jayasuriya, has already made investments in U.S.-based companies in areas such as mitochondrial health and oncology.
Kidron Capital, based in Tel Aviv, Israel, has recently announced the first close of its new venture capital fund that is specifically dedicated to women’s health. The fund is being led by Founding and Managing Partner Maria Gajda Horowitz and Co-founding and Managing Partner Dr. Anula Jayasuriya, both of whom have extensive academic and industry expertise in the healthtech sector.
As part of its investment strategy, the fund has already made investments in several U.S.-based companies focusing on different aspects of women’s health. These companies include Beyond Medicine, which focuses on mitochondrial health and menopausal symptoms, Portal, which aims to improve access to care for women facing cancer, and Renal Guard, which provides a solution to prevent Acute Kidney Injury during cardiac surgeries.
The fund plans to explore opportunities in women’s health across Europe, the USA, and Israel, targeting various sectors such as medical devices, diagnostics, digital health, therapeutics, and services. By adopting a diversified investment approach, the fund aims to impact multiple facets of women’s health and drive innovation in the field.
